The political landscape is abuzz with several key developments. President Trump's deal to end the war with Iran is facing increasing scrutiny, while Sen. Bernie Sanders has endorsed Cori Bush's comeback bid for her former congressional seat. Meanwhile, the FDA has approved a new over-the-counter opioid overdose nasal spray, and Todd Blanche is working to address concerns about potential DOJ payouts in his bid for confirmation.
Why It Matters
The FDA's approval of the new opioid overdose nasal spray is a significant development in the fight against the opioid epidemic. The spray, which can be administered without a prescription, has the potential to save lives and reduce costs. Meanwhile, Sen. Sanders' endorsement of Cori Bush's comeback bid highlights the ongoing struggle for progressive values in the Democratic Party.
What Experts Say
"Cori will take on AIPAC and other billionaire-backed special interests." — Sen. Bernie Sanders, on Cori Bush's comeback bid
Key Numbers
- 4 milligrams: the dosage of the new naloxone nasal spray approved by the FDA
- 3: the number of over-the-counter opioid overdose nasal sprays now available
- 2024: the year in which Cori Bush is seeking to reclaim her former congressional seat
Key Facts
- Who: Todd Blanche, Sen. Bernie Sanders, Cori Bush, President Trump
- What: FDA approval of new opioid overdose nasal spray, Sanders' endorsement of Bush's comeback bid, Trump's Iran deal
- When: Tuesday, with the Iran deal expected to be formally signed on Friday
- Where: Washington, D.C., Tehran, Switzerland
- Impact: The developments have significant implications for the fight against the opioid epidemic, progressive politics, and international relations.
What Comes Next
The fallout from President Trump's Iran deal is likely to continue, with critics calling for greater transparency and accountability. Meanwhile, Cori Bush's comeback bid will be closely watched as a test of progressive values in the Democratic Party. The FDA's approval of the new opioid overdose nasal spray is a positive development, but much work remains to be done to address the opioid epidemic.